#<p>p-value for comparison between HIV/HBV co-infected and the HIV mono-infected subjects.</p>*<p>p-value for comparison between HIV/HBV co-infected and the HIV<sup>+</sup>/anti-HCV<sup>+</sup> subjects.</p
<p>(A) CD4 T-cell count, (B) ALT, and (C) HBV DNA titres are represented as box and whisker plots fo...
A better understanding of how human immunodeficiency virus (HIV) coinfection affects the course of h...
<p>Median biomarker levels (pg/ml) are divided into 3 panels A) Inflammatory, chemokines; B) anti-in...
Comparative characteristics of HIV and hepatitis B or C coinfected (n = 2316) and not co-infected (n...
Characteristics at baseline of HIV/HCV co-infected patients included in this analysis—ANRS CO13 HEPA...
*<p>p<0.05 comparing the 3 HBV groups or comparing anti-HCV positive versus negative.</p>1<p>Missing...
<p>Baseline characteristics of all the participating HIV/HBV co-infected individuals belonging to di...
Comparative characteristics of HIV and hepatitis B or C coinfected (n = 2316) and not co-infected (n...
<p>*Evidence of HCV co-infection at any time up to time of the event/censoring date</p><p>**Includes...
<p>(N = 7473).</p>a<p>P-value reported using the Kruskal-Wallis test; <sup>b</sup> P-value not signi...
<p>Abbreviations: HCV, hepatitis C virus; HIV, human immunodeficiency virus; IDU, injection drug use...
Baseline characteristics of the 1391 HIV/HCV-coinfected patients from the ANRS CO13 HEPAVIH cohort; ...
<p>Socio demographic characteristics of HIV mono-infected and HIV/HCV co-infected subjects in the st...
CD4+ T-cell count and HIV viral load and their association with HBV and/or HCV in HIV-infected patie...
<p>Continuous variables were expressed as medians and interquartile ranges (IQR), and categorical va...
<p>(A) CD4 T-cell count, (B) ALT, and (C) HBV DNA titres are represented as box and whisker plots fo...
A better understanding of how human immunodeficiency virus (HIV) coinfection affects the course of h...
<p>Median biomarker levels (pg/ml) are divided into 3 panels A) Inflammatory, chemokines; B) anti-in...
Comparative characteristics of HIV and hepatitis B or C coinfected (n = 2316) and not co-infected (n...
Characteristics at baseline of HIV/HCV co-infected patients included in this analysis—ANRS CO13 HEPA...
*<p>p<0.05 comparing the 3 HBV groups or comparing anti-HCV positive versus negative.</p>1<p>Missing...
<p>Baseline characteristics of all the participating HIV/HBV co-infected individuals belonging to di...
Comparative characteristics of HIV and hepatitis B or C coinfected (n = 2316) and not co-infected (n...
<p>*Evidence of HCV co-infection at any time up to time of the event/censoring date</p><p>**Includes...
<p>(N = 7473).</p>a<p>P-value reported using the Kruskal-Wallis test; <sup>b</sup> P-value not signi...
<p>Abbreviations: HCV, hepatitis C virus; HIV, human immunodeficiency virus; IDU, injection drug use...
Baseline characteristics of the 1391 HIV/HCV-coinfected patients from the ANRS CO13 HEPAVIH cohort; ...
<p>Socio demographic characteristics of HIV mono-infected and HIV/HCV co-infected subjects in the st...
CD4+ T-cell count and HIV viral load and their association with HBV and/or HCV in HIV-infected patie...
<p>Continuous variables were expressed as medians and interquartile ranges (IQR), and categorical va...
<p>(A) CD4 T-cell count, (B) ALT, and (C) HBV DNA titres are represented as box and whisker plots fo...
A better understanding of how human immunodeficiency virus (HIV) coinfection affects the course of h...
<p>Median biomarker levels (pg/ml) are divided into 3 panels A) Inflammatory, chemokines; B) anti-in...